GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 28, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
7U0Q | P0DTC2 | SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-02 | |
7U0Q | 7U0Q | SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-02 | |
7UPL | P0DTC2 | SARS-Cov2 Omicron varient S protein structure in complex with neutralizing monoclonal antibody 002-S21F2 | |
7UPL | 7UPL | SARS-Cov2 Omicron varient S protein structure in complex with neutralizing monoclonal antibody 002-S21F2 | |
7E3B | P0DTC2 | SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD) | |
7E3B | 7E3B | SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD) | |
7WPH | P0DTC2 | SARS-CoV2 RBD bound to Fab06 | |
7WPH | 7WPH | SARS-CoV2 RBD bound to Fab06 | |
8C2R | P0DTC2 | SARS-CoV2 Omicron BA.1 spike in complex with CAB-A17 antibody | |
8C2R | 8C2R | SARS-CoV2 Omicron BA.1 spike in complex with CAB-A17 antibody | |
7B18 | P0DTC2 | SARS-CoV-spike bound to two neutralising nanobodies | Spike glycoprotein, Nanobody against SARS-CoV-2 VHH E, Nanobody against spike glycoprotein VHH V |
7B18 | 7B18 | SARS-CoV-spike bound to two neutralising nanobodies | Spike glycoprotein, Nanobody against SARS-CoV-2 VHH E, Nanobody against spike glycoprotein VHH V |
7B17 | P0DTC2 | SARS-CoV-spike RBD bound to two neutralising nanobodies. | |
7B17 | 7B17 | SARS-CoV-spike RBD bound to two neutralising nanobodies. | |
7XIL | P0DTC2 | SARS-CoV-2-Beta-RBD and B38-GWP/P-VK antibody complex | |
7XIL | 7XIL | SARS-CoV-2-Beta-RBD and B38-GWP/P-VK antibody complex | |
7RU2 | P0DTC2 | SARS-CoV-2-6P-Mut7 S protein (asymmetric) | |
7RU1 | P0DTC2 | SARS-CoV-2-6P-Mut7 S protein (C3 symmetry) | |
7S6I | P0DTC2 | SARS-CoV-2-6P-Mut2 S protein | |
8HC4 | P0DTC2 | SARS-CoV-2 wildtype spike trimer (6P) in complex with 3 YB9-258 Fabs and 3 R1-32 Fabs (3 RBD up) | |
8HC4 | 8HC4 | SARS-CoV-2 wildtype spike trimer (6P) in complex with 3 YB9-258 Fabs and 3 R1-32 Fabs (3 RBD up) | |
8HC5 | P0DTC2 | SARS-CoV-2 wildtype S1 in complex with YB9-258 Fab and R1-32 Fab | |
8HC5 | 8HC5 | SARS-CoV-2 wildtype S1 in complex with YB9-258 Fab and R1-32 Fab | |
8G70 | P0DTC2 | SARS-CoV-2 spike/nanobody mixture complex | |
8G70 | 8G70 | SARS-CoV-2 spike/nanobody mixture complex | |
8G77 | P0DTC2 | SARS-CoV-2 spike/Nb6 complex | |
8G77 | 8G77 | SARS-CoV-2 spike/Nb6 complex | |
8G76 | P0DTC2 | SARS-CoV-2 spike/Nb5 complex | |
8G76 | 8G76 | SARS-CoV-2 spike/Nb5 complex | |
8G75 | P0DTC2 | SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound | |
8G75 | 8G75 | SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound | |
8G73 | P0DTC2 | SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 bound at 2.5 A | |
8G73 | 8G73 | SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 bound at 2.5 A | |
8G7A | P0DTC2 | SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 (local refinement) | |
8G7A | 8G7A | SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 (local refinement) | |
8G7B | P0DTC2 | SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 (local refinement) | |
8G7B | 8G7B | SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 (local refinement) | |
8G74 | P0DTC2 | SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 | |
8G74 | 8G74 | SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 | |
7U9O | P0DTC2 | SARS-CoV-2 spike trimer RBD in complex with Fab NE12 | |
7U9O | 7U9O | SARS-CoV-2 spike trimer RBD in complex with Fab NE12 | |
7U9P | P0DTC2 | SARS-CoV-2 spike trimer RBD in complex with Fab NA8 | |
7U9P | 7U9P | SARS-CoV-2 spike trimer RBD in complex with Fab NA8 | |
7LO4 | Q9BYF1 | SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2 | |
7LO4 | P0DTC2 | SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2 | |
7R6W | 7R6W | SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2X35 Fab and S309 Fab | |
7R6W | P0DTC2 | SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2X35 Fab and S309 Fab | |
7R6X | 7R6X | SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2E12 Fab, S309 Fab, and S304 Fab | |
7R6X | P0DTC2 | SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2E12 Fab, S309 Fab, and S304 Fab | |
7CWU | P0DTC2 | SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail | Spike glycoprotein, heavy chain of P17 Fab, light chain of P17 Fab, heavy chain of FC05 Fab, light chain of FC05 Fab |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024